Gene · 5339
Papers2,747
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
341 to 360 of 2,747
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Effect of the Rho-Kinase/ROCK Signaling Pathway on Cytoskeleton Components. | Genes (Basel) | 2023 | 36833199 | PubTator, text mining | PubMed |
| Histidine oxidation in lytic polysaccharide monooxygenase. | J Biol Inorg Chem | 2023 | 36828975 | PubTator, text mining | PubMed |
| Transcriptomic analysis reveals the immune response of human microglia to a soy protein and collagen hybrid bioscaffold. | Heliyon | 2023 | 36825181 | PubTator, text mining | PubMed |
| Genome-wide association study of the age of onset of type 1 diabetes reveals HTATIP2 as a novel T cell regulator. | Front Immunol | 2023 | 36817429 | PubTator, text mining | PubMed |
| Systematic analysis of the BET family in adrenocortical carcinoma: The expression, prognosis, gene regulation network, and regulation targets. | Front Endocrinol (Lausanne) | 2023 | 36793283 | PubTator, text mining | PubMed |
| ASAP1 activates the IQGAP1/CDC42 pathway to promote tumor progression and chemotherapy resistance in gastric cancer. | Cell Death Dis | 2023 | 36792578 | PubTator, text mining | PubMed |
| Label-Free Proteomics of Oral Mucosa Tissue to Identify Potential Biomarkers That Can Flag Predilection of Precancerous Lesions to Oral Cell Carcinoma: A Preliminary Study. | Dis Markers | 2023 | 36776920 | PubTator, text mining | PubMed |
| Machine learning models for predicting steroid-resistant of nephrotic syndrome. | Front Immunol | 2023 | 36776850 | PubTator, text mining | PubMed |
| Integrative proteomic characterization of adenocarcinoma of esophagogastric junction. | Nat Commun | 2023 | 36774361 | PubTator, text mining | PubMed |
| Insights into the Molecular Mechanisms Regulating Cell Behavior in Response to Magnetic Materials and Magnetic Stimulation in Stem Cell (Neurogenic) Differentiation. | Int J Mol Sci | 2023 | 36768351 | PubTator, text mining | PubMed |
| UPF1-From mRNA Degradation to Human Disorders. | Cells | 2023 | 36766761 | PubTator, text mining | PubMed |
| Sialyl LewisX/A and Cytokeratin Crosstalk in Triple Negative Breast Cancer. | Cancers (Basel) | 2023 | 36765690 | PubTator, text mining | PubMed |
| Classification of Pancreatic Ductal Adenocarcinoma Using MALDI Mass Spectrometry Imaging Combined with Neural Networks. | Cancers (Basel) | 2023 | 36765644 | PubTator, text mining | PubMed |
| Cell cycle-dependent palmitoylation of protocadherin 7 by ZDHHC5 promotes successful cytokinesis. | J Cell Sci | 2023 | 36762613 | PubTator, text mining | PubMed |
| Platelets derived citrullinated proteins and microparticles are potential autoantibodies ACPA targets in RA patients. | Front Immunol | 2023 | 36761728 | PubTator, text mining | PubMed |
Clinical impact of volume of disease and time of metastatic disease presentation on patients receiving enzalutamide or abiraterone acetate plus prednisone as first-line therapy for metastatic castration-resistant prostate cancer. | J Transl Med | 2023 | 36737752 | PubTator, text mining | PubMed |
| Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | Mol Cell | 2023 | 36736316 | PubTator, text mining | PubMed |
| A deep tabular data learning model predicting cisplatin sensitivity identifies BCL2L1 dependency in cancer. | Comput Struct Biotechnol J | 2023 | 36733702 | PubTator, text mining | PubMed |
| Epithelial Barrier in the Nasal Mucosa, Related Risk Factors and Diseases. | Int Arch Allergy Immunol | 2023 | 36724763 | PubTator, text mining | PubMed |
| Transcriptome-wide analysis reveals the coregulation of RNA-binding proteins and alternative splicing genes in the development of atherosclerosis. | Sci Rep | 2023 | 36720950 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5339/papers?page=18